Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cysteine residues are responsible for the sulfurous off-flavor formed in heated whey protein solutions

ABSTRACT: Odor-active volatile sulfur compounds are formed in heated food protein systems. In the present study, hydrogen sulfide (H2S) was found to be the most abundant sulfur volatile in whey protein systems (whey protein isolate (WPI), a whey model system and single whey proteins) by Gas Chromatography-Flame Photometric Detector (GC-FPD) analysis after different heat treatments (60-90 C for 10 min, 90 C for 120 min and a UHT-like condition). Site-specific LC-MS/MS-based proteomic analysis was conducted to monitor desulfurization reactions in these protein systems to investigate the mechanism of H2S formation in heated WPI. H2S was detected in WPI after heating at 90 C for 10 min, and significantly increased at higher heat load (90 C for 120 min and the UHT treatment), which revealed the temperature- and time-dependence of heat-induced H2S generation in WPI. Cysteine (Cys) residues from beta-lactoglobulin were found to be responsible for the formation of H2S in heated WPI, presumably via beta-elimination.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Bos Taurus (ncbitaxon:9913)

SUBMITTER: Marianne Nissen Lund

PROVIDER: MSV000088811 | MassIVE | Thu Feb 10 02:24:00 GMT 2022

SECONDARY ACCESSION(S): PXD031568

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Oxidation of whey proteins during thermal treatment characterized by a site-specific LC-MS/MS-based proteomic approach

Project description:Thermal treatment is often employed in food processing to tailor product properties by manipulating ingredient functionality. However, due to the presence of oxidants in many food products, these elevated temperatures may accelerate oxidation and lead to the loss of nutrients. In the present study, oxidation of different whey protein systems (pure alpha-lactalbumin (a-LA), pure beta-lactoglobulin (b-LG), a mix of a-LA and b-LG (as a whey model) and a commercial whey protein isolate (WPI)) was investigated during heat treatment at 60-90 degreeC and a UHT-like condition by LC-MS-based proteomic analysis. The relative modification levels of each oxidation site were calculated and compared among different heat treatments and sample systems. The temperature- and time-dependent oxidation was detectable in protein systems after heating at and higher than 90 degreeC, while the extent of oxidation decreased with increasing complexity of the system (a-LA > b-LG > whey model > WPI). Trp residues in a-LA were found to be the amino acid residues most prone to oxidation during heat treatment. In b-LG-containing protein systems, Cys residues were suggested to scavenge most of the reactive oxidants and undergo oxidation-mediated disulfide rearrangement. The rearranged disulfide bonds contributed to protein aggregation (as confirmed by SDS-PAGE analysis), which was suggested to provide further physical protection against oxidation. However, no significant loss of amino acid residues was detected in the heated protein systems after acidic hydrolysis followed by HPLC analysis, which shows only a minor effect of heat treatment on protein oxidation in these pure protein systems.

2021-12-06 | MSV000088520 | MassIVE

Shewanella piezotolerans WP3 wild-type strain heat shock for 90 min

Project description:The WP3 strains was cultured at 20°C and heat shocked at 40°C for 90 min. The transcriptional profiles after and before heat shock were compared.

2016-06-15 | GSE82263 | GEO

Multicenter Phese II Study of SOX plus Bevacizumab Therapy with Oxaliplatin Stop-and-Go Strategy and Oral S-1 plus Bevacizumab Maintenance Therapy in Advanced Colorectal CancerC

Project description:Interventions: (1)Initial therapy : SOX+bevacizumab therapy Bev : 7.5 mg/kg (90 min) L-OHP : 130 mg/m2 (120 min) S-1 : 80 - 120 mg/day (Day1-15) (2)Maintenance therapy : S-1+bevacizumab therapy Bev : 7.5 mg/kg (90 min) S-1 : 80 - 120 mg/day (Day1-15) (3)Reintroduced therapy : SOX+bevacizumab therapy Primary outcome(s): DDC ; Duration of disease control) Study Design: Single arm Non-randomized

| 2627046 | ecrin-mdr-crc

Systems toxicology assessment of CHTP1.2 [RNE Data]

Project description:Modified risk tobacco products (MRTPs) have the potential to reduce smoking-related health risks. The Carbon Heated Tobacco Product 1.2 (CHTP1.2) is a potential MRTP that uses a pressed carbon heat source to generate an aerosol by heating tobacco. This study reports the results from the systems toxicology arm of a 90-day rat inhalation study (OECD test guideline 413) to assess the effects of CHTP1.2 aerosol compared with cigarette smoke (CS). Rats were exposed to filtered air (sham), to CHTP1.2 aerosol (at 15, 23 and 50 µg nicotine / L), or to the 3R4F reference cigarette smoke (at 23 µg nicotine / L).

2018-04-10 | E-MTAB-6320 | biostudies-arrayexpress

Systems toxicology assessment of CHTP1.2 [Liver Data]

2018-04-10 | E-MTAB-6317 | biostudies-arrayexpress

Systems toxicology assessment of CHTP1.2 [Lung Data]

2018-04-10 | E-MTAB-6319 | biostudies-arrayexpress

Shewanella piezotolerans WP3

Project description:Shewanella piezotolerans WP3 wild-type strain heat shock for 90 min

| PRJNA324483 | ENA

Systems toxicology assessment of CHTP1.2 [Lung Data]

Project description:Modified risk tobacco products (MRTPs) have the potential to reduce smoking-related health risks. The Carbon Heated Tobacco Product 1.2 (CHTP1.2) is a potential MRTP that uses a pressed carbon heat source to generate an aerosol by heating tobacco. This study reports the results from the systems toxicology arm of a 90-day rat inhalation study (OECD test guideline 413) to assess the effects of CHTP1.2 aerosol compared with cigarette smoke (CS). Rats were exposed to filtered air (sham), to CHTP1.2 aerosol (at 15, 23 and 50 Âµg nicotine / L), or to the 3R4F reference cigarette smoke (at 23 Âµg nicotine / L).

2018-03-19 | PXD008422 | Pride

Systems toxicology assessment of CHTP1.2 [RNE Data]

2018-03-19 | PXD008424 | Pride

Systems toxicology assessment of CHTP1.2 [Liver Data]

2018-03-19 | PXD008423 | Pride